Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001953845 | SCV002247285 | pathogenic | Congenital amegakaryocytic thrombocytopenia; Essential thrombocythemia | 2021-09-21 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr63*) in the MPL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MPL are known to be pathogenic (PMID: 8073287, 11133753). This variant is not present in population databases (ExAC no frequency). This premature translational stop signal has been observed in individual(s) with congenital amegakaryocytic thrombocytopenia (PMID: 17666371). For these reasons, this variant has been classified as Pathogenic. |